← brief for 2026-08-26 · Slowing decline

Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study.

Key takeaways

Researchers looked back through a large database of health records for adults with polycystic kidney disease, an inherited condition that fills the kidneys with fluid sacs and slowly destroys them. They compared people who took semaglutide, a diabetes and weight loss drug, with closely matched people who did not, and left out anyone on the other kidney drugs. Because this used past records rather than a planned trial, it can show a link between the drug and kidney outcomes, not proof that the drug caused them. The summary available here does not give the result numbers.

Who did this work

Chen TP · Tsai SF

Source

Article · PubMed, the drug frontier · 2026 Aug 26
https://pubmed.ncbi.nlm.nih.gov/42648283/